Cancer
At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Find out more about:
Bill Walsh Translational Cancer Research Laboratory
Bowel Cancer and Biomarker Research Lab
Breast Cancer Research
Cancer Genetics Laboratory
Kolling Institute Tumour Bank
Events, News and Seminars
Kolling researcher honoured with prestigious, international role
Posted on: 01 December, 2020
Congratulations to the Kolling’s Acting Executive Director Professor Chris Little following his ele..... Read more
Category: Research Excellence
Researchers offer new approach to detect frailty in older adults
Posted on: 23 November, 2020
A team of researchers led by the Kolling’s Professor Sarah Hilmer has developed a valuable resource ..... Read more
Category: New Treatment
Philanthropic funding brings new hope to those with chronic pain
Posted on: 12 November, 2020
Some of the nation’s leading pain experts are set to embark on research which they believe will chan..... Read more
Category: Funding support, New Treatment